Hiding in plain sight - platelets, the silent carriers of HIV-1

被引:3
作者
Baumer, Yvonne [1 ,2 ,3 ]
Weatherby, Tina M. [4 ]
Mitchell, Brooks I. [1 ]
SahBandar, Ivo N. [1 ,5 ]
Premeaux, Thomas A. [1 ]
Michelle, L. D'Antoni [1 ,6 ]
Gutierrez-Huerta, Cristhian A. [3 ]
Powell-Wiley, Tiffany M. [3 ]
Brown, Timothy R.
Boisvert, William A. [2 ]
Shikuma, Cecilia M. [5 ]
Ndhlovu, Lishomwa C. [1 ,5 ]
机构
[1] John A Burns Sch Med, Dept Trop Med, Honolulu, HI USA
[2] John A Burns Sch Med, Ctr Cardiovasc Res, Honolulu, HI USA
[3] NIH, NHLBI, Social Determinants Obes & Cardiovasc Risk Lab, Bethesda, MD USA
[4] Univ Hawaii, Pacific Biomed Res Ctr, Biol Elect Microscope Facil, Honolulu, HI 96822 USA
[5] John A Burns Sch Med, Hawaii Ctr AIDS, Honolulu, HI USA
[6] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
HIV-1; reservoir; persistence; platelets; monocytes; MONOCYTES; VIREMIA;
D O I
10.1080/09537104.2020.1849606
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
There are approximately 38 million people globally living with Human immunodeficiency virus 1 (HIV-1) and given the tremendous success of combination antiretroviral therapy (cART) this has dramatically reduced mortality and morbidity with prevention benefits. However, HIV-1 persists during cART within the human body and re-appears upon cART interruption. This HIV-1 reservoir remains a barrier to cure with cellular sites of viral persistence not fully understood. In this study we provide evidence corroborating a recently published article in STM demonstrating the role of platelets as a novel cellular disseminator of HIV-1 particles in the setting of viral suppression. Using classical transmission electron microscopy with and without immunogold labeling, we visualize HIV-1 in both platelets and monocytes in cART suppressed HIV donors. Our study suggests that due to the close proximity of platelets and monocytes an alternative life cycle of HIV-1 cycling within monocytes and platelets without the need of active replication under cART occurs. Our findings are supported by the lack of detectable HIV-1 particles in platelets derived from HIV uninfected donors or the 'Berlin' patient suggesting that platelets may serve as an underappreciated hidden bearer for HIV-1 and should be considered in HIV remission studies and trials.
引用
收藏
页码:1038 / 1042
页数:5
相关论文
共 27 条
  • [11] Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
    Ho, Ya-Chi
    Shan, Liang
    Hosmane, Nina N.
    Wang, Jeffrey
    Laskey, Sarah B.
    Rosenbloom, Daniel I. S.
    Lai, Jun
    Blankson, Joel N.
    Siliciano, Janet D.
    Siliciano, Robert F.
    [J]. CELL, 2013, 155 (03) : 540 - 551
  • [12] Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
    Huetter, Gero
    Nowak, Daniel
    Mossner, Maximilian
    Ganepola, Susanne
    Muessig, Arne
    Allers, Kristina
    Schneider, Thomas
    Hofmann, Joerg
    Kuecherer, Claudia
    Blau, Olga
    Blau, Igor W.
    Hofmann, Wolf K.
    Thiel, Eckhard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) : 692 - 698
  • [13] Macrophage Bridging Conduit Trafficking of HIV-1 Through the Endoplasmic Reticulum and Golgi Network
    Kadiu, Irena
    Gendelman, Howard E.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2011, 10 (07) : 3225 - 3238
  • [14] Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
    Le Douce, Valentin
    Herbein, Georges
    Rohr, Olivier
    Schwartz, Christian
    [J]. RETROVIROLOGY, 2010, 7
  • [15] Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection
    Liang, Hua
    Duan, Zhaojun
    Li, Dan
    Li, Dongliang
    Wang, Zheng
    Ren, Li
    Shen, Tao
    Shao, Yiming
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (04) : 435 - 443
  • [16] Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy
    Massanella, Marta
    Bakeman, Wendy
    Sithinamsuwan, Pasiri
    Fletcher, James L. K.
    Chomchey, Nitiya
    Tipsuk, Somporn
    Chalermchai, Thep
    Routy, Jean-Pierre
    Ananworanich, Jintanat
    Valcour, Victor G.
    Chomont, Nicolas
    [J]. JOURNAL OF VIROLOGY, 2020, 94 (01)
  • [17] Impact of Myeloid Reservoirs in HIV Cure Trials
    Mitchell, Brooks I.
    Laws, Elizabeth I.
    Ndhlovu, Lishomwa C.
    [J]. CURRENT HIV/AIDS REPORTS, 2019, 16 (02) : 129 - 140
  • [18] Emerging roles for platelets as immune and inflammatory cells
    Morrell, Craig N.
    Aggrey, Angela A.
    Chapman, Lesley M.
    Modjeski, Kristina L.
    [J]. BLOOD, 2014, 123 (18) : 2759 - 2767
  • [19] Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
    Palmer, Sarah
    Malclarelli, Frank
    Wiegand, Ann
    Bernstein, Barry
    Hanna, George J.
    Brun, Scott C.
    Kempf, Dale J.
    Mellors, John W.
    Coffin, John M.
    King, Martin S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) : 3879 - 3884
  • [20] Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4+ T cell recovery can harbor replication-competent HIV despite viral suppression
    Real, Fernando
    Capron, Claude
    Sennepin, Alexis
    Arrigucci, Riccardo
    Zhu, Aiwei
    Sannier, Geremy
    Zheng, Jonathan
    Xu, Lin
    Masse, Jean-Marc
    Greffe, Segolene
    Cazabat, Michelle
    Donoso, Maribel
    Delobel, Pierre
    Izopet, Jacques
    Eugenin, Eliseo
    Gennaro, Maria Laura
    Rouveix, Elisabeth
    Borde, Elisabeth Cramer
    Bomsel, Morgane
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (535)